Literature DB >> 7458076

Ultrathin needle aspiration of the lung in infectious and malignant disease.

D C Zavala, J E Schoell.   

Abstract

Fifty patients with either malignant (n = 25) or infectious/inflammatory (n = 25) chest lesions had lung aspirations using ultrathin needles, 24 to 25 gauge. The procedure's overall sensitivity was 87%, and the specificity was 100%. The diagnostic yield was 90% (9/10) from peripheral malignant coin lesions, 100% (3/3) from malignant cavities, and 42% (5/12) from infected, nonmalignant cavities. Antimicrobial therapy probably contributed to poor microbiologic results in the latter group. Twenty-two of the patients previously had flexible fiberoptic bronchoscopy with negative results. In this select group, a diagnosis was established in 45% (10/22): 7 had malignant lesions, 2 had anaerobic lung abscesses, and 1 had histoplasmosis. In patients with infectious diseases, a variety of bacterial, mycobacterial, and fungal infections were confirmed including the diagnosis of Legionella pneumophila in 2 patients. A definitive diagnosis was obtained in 6 of 8 immunosuppressed patients who presented with indeterminate infiltrates on chest radiographs. Complications were minimal, although 21 patients (42%) had COPD, and 13 patients (26%) had moderate to severe hypoxemia (PaO2, 40 60 torr). Mild hemoptysis occurred in 2 patients (4%), and pneumothorax occurred in 4 patients (8%) of whom 2 required chest tube insertion. When compared with other studies using large gauge needles (18 to 22 gauge), ultrathin needle aspiration of the lung produced fewer complications, while maintaining an exceptionally good diagnostic yield.

Entities:  

Mesh:

Year:  1981        PMID: 7458076     DOI: 10.1164/arrd.1981.123.1.125

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

Review 1.  Biopsy needle characteristics.

Authors:  G S Gazelle; J R Haaga
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jan-Feb       Impact factor: 2.740

2.  The biocompatibility of compressed collagen foam plugs.

Authors:  J D Robinson; J W Yedlicka; M C Bildsoe; Z Vlodaver; D W Hunter; W Castañeda-Zúñiga; K Amplatz
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Feb-Mar       Impact factor: 2.740

3.  Chronic pulmonary paracoccidioidomycosis in the state of Rio Grande do Sul, Brazil.

Authors:  J W dos Santos; L C Severo; N da S Porto; J da S Moreira; L C da Silva; J J Carmargo
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 4.  Procedures for the diagnosis of pneumonia in ICU patients.

Authors:  J Chastre; J Y Fagon; C Lamer
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

5.  Needle aspiration techniques in the diagnosis of pneumonia.

Authors:  F Manresa; J Dorca
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

Review 6.  Biopsies in patients with intrathoracic disease.

Authors:  G A Lillington; W SooHoo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

Review 7.  Pulmonary infections in immunocompromised children.

Authors:  V P Choudhry; S Choudhary
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 8.  Ultrathin needle (25 G) aspiration lung biopsy: diagnostic accuracy and complication rates.

Authors:  Anastasia Oikonomou; Frederick R Matzinger; Jean M Seely; Carole J Dennie; Peter J Macleod
Journal:  Eur Radiol       Date:  2003-10-09       Impact factor: 5.315

9.  Value of bacterial antigen detection in the diagnostic yield of transthoracic needle aspiration in severe community acquired pneumonia.

Authors:  F Bella; J Tort; M A Morera; J Espaulella; J Armengol
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

10.  Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer.

Authors:  M Scudeletti; G Filaci; M A Imro; G Motta; M Di Gaetano; I Pierri; S Tongiani; F Indiveri; F Puppo
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.